Solid Tumors Harboring NTRK Fusion Completed Phase 1 Trials for Larotrectinib (DB14723)

Also known as: Solid Tumors Harbouring NTRK Fusion / Solid Tumors Habouring NTRK Fusion

IndicationStatusPhase
DBCOND0117977 (Solid Tumors Harboring NTRK Fusion)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02122913A Study to Test the Safety of the Investigational Drug Larotrectinib in Adults That May Treat CancerTreatment